Meeting
2020 ASCO Virtual Scientific Program
Genome Wide Association Study (GWAS) of cognitive impairment after blood or marrow transplantation (BMT) for hematologic malignancy.
Authors
Noha Sharafeldin
University of Alabama at Birmingham, Birmingham, AL
Noha Sharafeldin , Purnima Singh , Alysia Bosworth , Akinyemi I Ojesina , Jianqing Zhang , Yanjun Chen , Sunita K. Patel , Xuexia Wang , Liton Francisco , Stephen J. Forman , F. Lennie Wong , Smita Bhatia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Genetics
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1536)
DOI
10.1200/JCO.2020.38.15_suppl.1536
Abstract #
1536
Poster Bd #
28
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Genetic polymorphisms associated with clostridium difficile infection in multiple myeloma patients undergoing autologous stem cell transplantation.
First Author: Issam Hamadeh
Poster
2019 ASCO Annual Meeting
Candidate SNPs enhance prediction of cognitive impairment after blood or marrow transplantation (BMT) for hematologic malignancy (HM).
First Author: Noha Sharafeldin
Poster
2016 ASCO Annual Meeting
A genome-wide association study (GWAS) of progression-free survival (PFS) in metastatic breast cancer (MBC) patients treated with letrozole (L) with or without bevacizumab (B) in CALGB 40503.
First Author: Federico Innocenti
Poster
2016 ASCO Annual Meeting
Genome wide association study for anthracycline-induced congestive heart failure.
First Author: Laura Gardner